{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T03:37:44Z","timestamp":1779334664952,"version":"3.51.4"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"26","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1097\/md.0000000000004044","type":"journal-article","created":{"date-parts":[[2016,7,4]],"date-time":"2016-07-04T11:24:04Z","timestamp":1467631444000},"page":"e4044","source":"Crossref","is-referenced-by-count":6,"title":["Diffuse alveolar damage in a patient with rheumatoid arthritis under prolonged leflunomide treatment"],"prefix":"10.1097","volume":"95","author":[{"given":"Li-Ta","family":"Keng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mong-Wei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsien-Neng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuei-Pin","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-61-20210309","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1001\/archinte.159.21.2542","article-title":"Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group","volume":"159","author":"Strand","year":"1999","journal-title":"Arch Intern Med"},{"key":"R2-61-20210309","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0140-6736(98)09403-3","article-title":"Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group","volume":"353","author":"Smolen","year":"1999","journal-title":"Lancet"},{"key":"R3-61-20210309","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/art.11015","article-title":"The efficacy and safety of leflunomide in patients with active rheumatoid arthritis: a five-year followup study","volume":"48","author":"Kalden","year":"2003","journal-title":"Arthritis Rheum"},{"key":"R4-61-20210309","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1378\/chest.09-0444","article-title":"Rheumatoid arthritis-associated interstitial lung disease: the relevance of histopathologic and radiographic pattern","volume":"136","author":"Kim","year":"2009","journal-title":"Chest"},{"key":"R5-61-20210309","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1586\/1744666X.2013.811173","article-title":"Lung involvement and drug-induced lung disease in patients with rheumatoid arthritis","volume":"9","author":"Atzeni","year":"2013","journal-title":"Expert Rev Clin Immunol"},{"key":"R6-61-20210309","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1378\/chest.127.6.2019","article-title":"Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease","volume":"127","author":"Lee","year":"2005","journal-title":"Chest"},{"key":"R7-61-20210309","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1148\/radiol.2321030174","article-title":"Rheumatoid arthritis-related lung diseases: CT findings","volume":"232","author":"Tanaka","year":"2004","journal-title":"Radiology"},{"key":"R8-61-20210309","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1097\/00004728-199911000-00021","article-title":"Thin-section CT findings in rheumatoid arthritis-associated lung disease: CT patterns and their courses","volume":"23","author":"Akira","year":"1999","journal-title":"J Comput Assist Tomogr"},{"key":"R9-61-20210309","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00296-004-0527-0","article-title":"Nonspecific interstitial pneumonia pattern as pulmonary involvement of rheumatoid arthritis","volume":"26","author":"Yoshinouchi","year":"2005","journal-title":"Rheumatol Int"},{"key":"R10-61-20210309","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1378\/chest.130.2.553","article-title":"Diffuse alveolar damage: uncommon manifestation of pulmonary involvement in patients with connective tissue diseases","volume":"130","author":"Parambil","year":"2006","journal-title":"Chest"},{"key":"R11-61-20210309","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1517\/14740338.2011.560835","article-title":"Leflunomide-induced interstitial pneumonitis might be a representative of disease-modifying antirheumatic drug-induced lung injury","volume":"10","author":"Inokuma","year":"2011","journal-title":"Expert Opin Drug Saf"},{"key":"R12-61-20210309","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.2169\/internalmedicine.43.1201","article-title":"Rheumatoid arthritis complicated with acute interstitial pneumonia induced by leflunomide as an adverse reaction","volume":"43","author":"Kamata","year":"2004","journal-title":"Intern Med"},{"key":"R13-61-20210309","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(04)15527-X","article-title":"Japan deaths spark concerns over arthritis drug","volume":"363","author":"McCurry","year":"2004","journal-title":"Lancet"},{"key":"R14-61-20210309","first-page":"1160","article-title":"Leflunomide induced acute interstitial pneumonia","volume":"32","author":"Takeishi","year":"2005","journal-title":"J Rheumatol"},{"key":"R15-61-20210309","doi-asserted-by":"crossref","first-page":"689","DOI":"10.2169\/internalmedicine.45.1455","article-title":"Leflunomide-induced pneumonitis in a patient with rheumatoid arthritis","volume":"45","author":"Hirabayashi","year":"2006","journal-title":"Intern Med"},{"key":"R16-61-20210309","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3109\/s10165-008-0088-2","article-title":"Proposals for leflunomide use to avoid lung injury in patients with rheumatoid arthritis","volume":"18","author":"Inokuma","year":"2008","journal-title":"Mod Rheumatol"},{"key":"R17-61-20210309","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1093\/rheumatology\/kep052","article-title":"Leflunomide-induced interstitial lung disease: prevalence and risk factors in Japanese patients with rheumatoid arthritis","volume":"48","author":"Sawada","year":"2009","journal-title":"Rheumatology (Oxford"},{"key":"R18-61-20210309","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1093\/rheumatology\/kep227","article-title":"Factors associated with fatal outcome of leflunomide-induced lung injury in Japanese patients with rheumatoid arthritis","volume":"48","author":"Sato","year":"2009","journal-title":"Rheumatology (Oxford"},{"key":"R19-61-20210309","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/RHU.0b013e3181c3f87e","article-title":"Successful treatment of leflunomide-induced acute pneumonitis with cholestyramine wash-out therapy","volume":"15","author":"Wong","year":"2009","journal-title":"J Clin Rheumatol"},{"key":"R20-61-20210309","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/art.21806","article-title":"Leflunomide use and the risk of interstitial lung disease in rheumatoid arthritis","volume":"54","author":"Suissa","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R21-61-20210309","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1038\/cdd.2010.64","article-title":"Induction of EMT-like phenotypes by an active metabolite of leflunomide and its contribution to pulmonary fibrosis","volume":"17","author":"Namba","year":"2010","journal-title":"Cell Death Differ"},{"key":"R22-61-20210309","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1445-5994.2006.01035.x","article-title":"Pneumonitis associated with leflunomide: a profile of New Zealand and Australian reports","volume":"36","author":"Savage","year":"2006","journal-title":"Intern Med J"},{"key":"R23-61-20210309","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1002\/art.22666","article-title":"Risk of interstitial lung disease associated with leflunomide treatment in Korean patients with rheumatoid arthritis","volume":"56","author":"Ju","year":"2007","journal-title":"Arthritis Rheum"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000004044","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:27:39Z","timestamp":1620959259000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201606280-00061"}},"subtitle":["A Case Report and Literature Review"],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":23,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000004044","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]}}}